Categories
The Cordis INFINITI Angiographic Catheter is being recalled due to some of the products being shipped to end users without undergoing sterilization procedures.
Categories
FDA, USDA and EPA Propose National Strategy to Reduce U.S. Food Loss and Waste
FDA, USDA and EPA Propose National Strategy to Reduce U.S. Food Loss and Waste
http://www.fda.gov/news-events/press-announcements/fda-usda-and-epa-propose-national-strategy-reduce-us-food-loss-and-waste
Categories
Voluntary Recall of SoClean Equipment Intended for Use with CPAP Devices and Accessories: FDA Safety Communication
A voluntary recall initiated by SoClean for use of SoClean2 and SoClean3 equipment to clean, sanitize or disinfect CPAP devices and accessories.
Categories
FDA Roundup: December 1, 2023
FDA Roundup: December 1, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-1-2023
Categories
Eitan Medical Ltd Recalls Sapphire Infusion Pumps for Failure to Detect Air in the Line
Sapphire Infusion Pumps are being recalled because they may fail to detect air in the line. The failure could cause injury or death.
Categories
Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion Volume
Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump. The Correction is due to the potential for an incomplete infusion following one or more downstream occlusion alarms. Baxter notified impacted customers in October and i
Categories
Meta Herbal Issues Voluntary Nationwide Recall of Magnum XXL 9800 Capsules Due to Presence of Undeclared Sildenafil
E. Hampton NY- Meta Herbal is voluntarily recalling 500 blister packs of Magnum XXL 9800 2000 mg per capsule, to the consumer level. The products have been found to be tainted with Sildenafil. Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) found in FDA-approved products f
Categories
Left Atrial Appendage Occlusion (LAAO) Devices Potentially Associated with Procedural Outcome Differences Between Women and Men – Letter to Health Care Providers
Recommendations for health care providers due to potential procedural outcome differences between women and men undergoing procedures with LAAO devices.
Categories
FDA Roundup: November 28, 2023
FDA Roundup: November 28, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-28-2023
Categories
FDA Cautions Public of Safety Issue with Philips’ DreamStation 2 CPAP Machines
FDA Cautions Public of Safety Issue with Philips’ DreamStation 2 CPAP Machines
http://www.fda.gov/news-events/press-announcements/fda-cautions-public-safety-issue-philips-dreamstation-2-cpap-machines